ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Outcome"

  • 2022 American Transplant Congress

    Tele-Health Implementation During Covid19 Pandemic in Liver Transplant Population: A Focus on Medication Adherence, Patient Satisfaction, Clinical Outcomes and Possible Cost Impact

    H. Joharji, S. Alghamdi, S. Alqahtani, M. F. Janju, J. Khader, D. Alissa, A. Aljedai, D. Alkortas, K. Bezaizi, D. Broering, A. Ajlan, W. K. Al-Hamoudi, E. Devol, A. Albinmosa, S. Alabbad, Z. Alabdulkarim, A. Zidan, R. Alamawi, E. Alshammari, E. Alharthi, D. Al-Anazi, A. Almalki, M. Alasmari

    Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

    *Purpose: The COVID-19 pandemic affected many aspects of health care, including the provision of care in ambulatory care clinics, necessitating the utilization of telehealth. For…
  • 2022 American Transplant Congress

    The Role of Advanced Practice Providers in Liver Transplant Centers

    S. Nargiso, L. Sher, V. Tristan

    Keck Medical Center at University of Southern California, Los Angeles, CA

    *Purpose: Care for the liver transplant (LT) recipient requires expertise and consistency. Due to the rotation of trainees and the emphasis on surgical experience for…
  • 2022 American Transplant Congress

    Barriers and Facilitators to Care for Patients with Failed Kidney Transplants

    A. Huml1, K. Berg2, A. Perzynski2, C. Sullivan2, A. Sehgal2

    1Department of Kidney Medicine, Cleveland Clinic, Cleveland, OH, 2Population Health Research Institute, The MetroHealth System, Cleveland, OH

    *Purpose: To understand the barriers and facilitators to care for patients with failed kidney transplants from the perspective of providers.*Methods: Qualitative study employed focus groups…
  • 2022 American Transplant Congress

    Outcomes of a Standardized Antibody-Mediated Rejection (AMR) Treatment Protocol in Heart Transplant Recipients (HTR)

    J. Lee, T. Sam, J. Van Zyl, S. Mckean, L. Fuller, N. Wilson, A. Dao, R. Gottlieb, S. Hall, R. Patel

    Baylor University Medical Center, Dallas, TX

    *Purpose: AMR in HTR portends poor clinical outcomes. Reported mortality range between 20-50%, with higher rates reported for late AMR occurring at least 1 year…
  • 2022 American Transplant Congress

    Impact of MMaT Policy on Transplant for Hepatocellular Carcinoma at a Single Center

    S. Kodali1, D. W. Victor2, J. Corkrean2, A. Shetty2, C. Mobley2, M. Hobeika2, R. McMillan2, E. A. Graviss3, D. T. Nguyen3, R. McFadden4, V. Ankoma-Sey2, C. Egwim5, J. Galati2, A. Saharia2, R. M. Ghobrial2

    1Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Sugarland, TX, 2Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Houston, TX, 3Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, 4Department of Medicine, Hepatology, Houston Methodist Hospital, Houston, TX, 5Houston Methodist Hospital, Houston, TX

    *Purpose: Hepatocellular carcinoma (HCC) is the most common primary malignant hepatic tumor. Currently, liver transplantation may be the optimal treatment for HCC. Patient selection criteria…
  • 2022 American Transplant Congress

    Outcomes of Sensitized Simultaneous Liver-Kidney Transplant

    E. R. Kitchel, T. Tan, A. Wadhwa, D. G. Farmer, S. Bunnapradist

    David Geffen School of Medicine, Los Angeles, CA

    *Purpose: Pre-formed donor-specific HLA antibodies (DSAs) in simultaneous liver-kidney transplants (SLKTs) have been associated with increased risk of antibody mediated rejection (AMR) and negative transplant…
  • 2022 American Transplant Congress

    Excessive Weight Gain Does Not Associate with Poorer Graft Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients – A Single-Center Experience

    N. Eleti, G. Agarwal, S. Ong, C. Kew, D. Anderson, C. Young

    University of Alabama at Birmingham, Birmingham, AL

    *Purpose: Weight gain is common following organ transplantation, and there exists concern that in simultaneous pancreas-kidney (SPK) recipients, this may lead to poorer graft outcomes.*Methods:…
  • 2022 American Transplant Congress

    Impact of Late and Recurrent Acute Graft Pyelonephritis on Long-Term Kidney Graft Outcomes

    M. Pacaud1, L. Colas1, C. Kerleau2, F. Le Borgne3, M. Giral2, S. Brouard1, J. Dantal2

    1CRT2I, Université de Nantes, Nantes, France, 2Service de Néphrologie et immunologie clinique, CHU de Nantes, Nantes, France, 3INSERM UMR 1246-SPHERE, Université de Nantes, Nantes, France

    *Purpose: While Urinary tract infections are the most common infections in kidney transplant recipients, the impact of late acute graft pyelonephritis (AGPN) on graft outcomes…
  • 2022 American Transplant Congress

    Textbook Outcome in Lung Transplantation: Planned VA ECMO versus Off-Pump

    S. E. Halpern1, M. C. Wright2, G. Madsen2, B. Chow2, J. C. Haney3, J. A. Klapper3, B. A. Bottiger2, M. G. Hartwig3

    1Duke University School of Medicine, Durham, NC, 2Anesthesiology, Duke University Medical Center, Durham, NC, 3Surgery, Duke University Medical Center, Durham, NC

    *Purpose: Planned venoarterial extracorporeal membrane oxygenation (VA ECMO) is increasingly used during bilateral orthotopic lung transplantation (BOLT) and may be superior to off-pump (OP) support…
  • 2022 American Transplant Congress

    Outcomes of Primary Simultaneous Pancreas-Kidney Transplants by Induction Agent in the United States

    A. Cerise1, T. Shaker1, K. Ramanathan1, S. Jackson2, R. Kandaswamy1, S. Riad3

    1Surgery, University of Minnesota, Minneapolis, MN, 2Analytics, MHealth-Fairview, Minneapolis, MN, 3Medicine, University of Minnesota, Minneapolis, MN

    *Purpose: Induction immunosuppression choice for simultaneous pancreas-kidney (SPK) transplants varies widely in the United States. We examined the association between induction agents and outcomes of…
  • 1
  • 2
  • 3
  • …
  • 155
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2023 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences